London-based FundamentalVR, maker of a virtual reality surgical training platform, announced last week it had scored $20 million in Series B funding.
The round was led by EQT Life Sciences and joined by previous investor Downing Ventures.
FundamentalVR most recently closed a $5 million Series A in 2019. The latest raise brings the startup's total funding to more than $30 million.
WHAT IT DOES...
A clinical trial in New Zealand found a virtual reality app-based cognitive behaviour therapy programme reduced the symptoms of common phobias.
FINDINGS
Conducted between May and December last year, the randomised, controlled trial recruited a total of 129 adult participants with fears of flying, heights, needles, spiders and dogs. It was led by Dr Cameron Lacey, associate professor from the...
A virtual reality therapeutic program reduces pain intensity up to six months later, compared with a sham app, according to a study published in JMIR.
The study was sponsored by AppliedVR and used its RelieVRx system, formerly known as EaseVRx, to assess its long-term effectiveness for people with chronic lower-back pain (CLBP). It followed up on earlier research that analyzed the immersive eight...
A virtual reality pain management intervention worked as well as guided imagery among children and young adults undergoing unsedated procedures, according to a study published in JMIR. However, the tools had different effects depending on patients' anxious tendencies.
Researchers recruited children and young adults from hematology, oncology, and blood and marrow transplant clinics at a children’...
NexStem, a robotics startup based in Palo Alto, California with a R&D team in India, is set to roll out across Asia-Pacific, Europe and the United States its headset that can be controlled by a user's thoughts.
The launch comes as the company has received funding from angel investors like BITS Spark and Indian internet company InfoEdge for an undisclosed amount.
WHAT IT'S FOR
NexStem offers...
Late last year, virtual reality therapeutic company AppliedVR scored FDA De Novo clearance for its EaseVRx system for treating chronic lower back pain.
The eight-week virtual reality program is designed to help people control and modulate their pain, AppliedVR cofounder and CEO Matthew Stoudt told MobiHealthNews. The system uses regulation and mindfulness skills, as well as techniques from...
Japanese medical device maker Jolly Good and the Pain Center at the Aichi Medical University Hospital will conduct a study on the efficacy of virtual reality-based therapy for chronic pain.
It was in April last year that Jolly Good set up its digital therapeutics division, which involves a team of psychiatrists, pharmaceutical strategy specialists, and other DTx specialists. Through this, the...
A virtual reality-based right heart catheter training programme will soon come to Vantari VR's platform.
The Australian VR startup has partnered with Dr Martin Brown, a cardiologist and associate clinical professor at Macquarie University, who first developed the training course with Janssen Pharmaceuticals in 2017. The training programme has since been approved by the Cardiac Society of...
PrecisionOS scored FDA 510(k) clearance for its InVisionOS tool that allows surgeons to plan operations using virtual reality.
The software, which officially received the FDA greenlight earlier in November, will be available early next year. It takes a patient’s CT scan and creates a 3D construction that a surgeon can then view and manipulate with an Oculus Quest 2. They can also use VR to focus...
The Food and Drug Administration has granted AppliedVR De Novo clearance to market its EaseVRx virtual reality system to treat chronic lower back pain.
The prescription device includes a VR headset and controller plus a “Breathing Amplifier” that’s used to train the user in deep breathing. Patients can participate in 56 VR sessions that use cognitive behavioral therapy to treat pain. The...